Oncolytics Biotech reports durable survival data for pelareorep in anal cancer and its potential role across HPV-driven cancers

Observed price moves

• ONCY+5.98%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.